In 2026, a new treatment for HER2-positive breast cancer, 'Tukysa' (generic name: tucatinib), was approved in Japan.I am ...
An updated meta-analysis of six randomized controlled trials finds that Limosilactobacillus reuteri DSM 17938 modestly ...
As if the diarrhea situation couldn't get any worse, the Centers for Disease Control and Prevention (CDC) is warning about an ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results